NCT05277753 2022-03-15
NGS-MRD Assessment of Combination Immunotherapies Targeting T-ALL
Shenzhen Geno-Immune Medical Institute
Phase 1 Unknown
Clinical Trials
1 trialsOTHER × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × S-1,2-dichlorovinyl-N-acetylcysteine × Clear all